Granules Share Price Target Tomorrow 2024 To 2030 and More Details

Granules India Ltd is an Indian pharmaceutical company known for producing high-quality, affordable medicines. Established in 1984, the company specializes in manufacturing Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages. Their products are used to treat common health conditions like pain relief, diabetes, and hypertension.

Granules India exports its medicines to over 75 countries and works with some of the world’s leading pharmaceutical companies. Granules Share Price on NSE as of 16 October 2024 is 604.85 INR. Here will provide you more details on Granules Share Price Target 2024, 2025, 2026 to 2030.

Granules India Ltd: Market Overview

• Open Price: ₹599.90
• High Price: ₹599.90
• Low Price: ₹599.90
• Previous Close: ₹599.65
• Volume: 43,481
• Value (Lacs): ₹260.95
• VWAP: ₹600.30
• UC Limit: ₹659.60
• LC Limit: ₹539.70
• P/E ratio: 29.56
• Div yield: 0.25%
• 52-wk high: ₹721.00
• 52-wk low: ₹318.95
• Mkt cap: ₹14.54KCr
• Face Value: ₹1

Granules India Ltd Competitors

Here are five competitor companies of Granules India Ltd, along with their approximate market capitalizations (as of recent data):

1. Aurobindo Pharma Ltd
   • Market Capitalization: ~$4.6 billion
   • A leading global pharmaceutical company, Aurobindo produces APIs, generic formulations, and nutraceuticals across multiple therapeutic areas.
2. Sun Pharmaceutical Industries Ltd
   • Market Capitalization: ~$33 billion
   • One of India’s largest pharmaceutical companies, Sun Pharma manufactures and sells medicines globally, specializing in generic drugs, branded generics, and APIs.
3. Cipla Ltd
   • Market Capitalization: ~$12.8 billion
   • Cipla is a major pharmaceutical company focusing on respiratory, antiretroviral, urology, and cardiovascular treatments, along with APIs and generic formulations.
4. Dr. Reddy’s Laboratories Ltd
   • Market Capitalization: ~$10.8 billion
   • Dr. Reddy’s is a global pharmaceutical company offering a wide range of products, including APIs, generic drugs, and over-the-counter medicines.

5. Lupin Ltd

   • Market Capitalization: ~$6.4 billion
   • Lupin is a leading multinational pharmaceutical company engaged in manufacturing branded and generic drugs, biosimilars, and APIs across various therapeutic segments.

Granules Share Price Chart

Granules Share Price Target Tomorrow 2024 To 2030

Granules Share Price Target 2024

Granules share price target 2024 Expected target could be ₹750. Here are three key factors that could affect the growth of Granules India Ltd’s share price target for 2024:

• Demand for Generic Medicines: Granules India specializes in producing affordable generic drugs. As the demand for generics rises globally, particularly in key markets like the U.S. and Europe, the company’s revenue could increase, positively impacting its share price.
• Expansion of Product Portfolio: Granules India’s growth strategy includes expanding its product offerings and entering new therapeutic areas. Successful launches of new drugs, especially in high-demand segments, could drive earnings growth and boost investor confidence in 2024.

• Regulatory Approvals and Compliance: The company’s ability to maintain regulatory compliance and secure approvals from authorities like the U.S. FDA for new product launches or manufacturing facilities will be crucial. Any regulatory setbacks could affect investor sentiment, while successful approvals can lead to positive stock performance.

Granules Share Price Target 2025

Granules share price target 2025 Expected target could be ₹865. Here are three key factors that could affect the growth of Granules India Ltd’s share price target for 2025:

• Global Market Expansion and Exports: Granules India’s efforts to expand into new international markets, especially in regions like North America, Europe, and emerging markets, will be critical. Increased exports and market penetration can significantly boost revenues and influence the company’s share price in 2025.
• Cost Management and Operational Efficiency: The company’s ability to manage costs and improve production efficiency, especially in a competitive generic drug market, will be important for maintaining profitability. Lower production costs and optimized supply chains could lead to improved margins and a stronger stock performance.

• Strategic Partnerships and Acquisitions: Partnerships with other pharmaceutical companies or potential acquisitions to enhance its product pipeline and market presence could be a major growth driver. Successful collaborations or mergers could unlock new revenue streams and positively impact Granules India’s share price by 2025.

Granules Share Price Target 2030

Granules share price target 2030 Expected target could be ₹1692. Here are three key factors that could affect the growth of Granules India Ltd’s share price target for 2030:

• Long-Term Growth in Healthcare Demand: By 2030, the global demand for affordable healthcare and generic medicines is expected to rise, especially in aging populations and emerging markets. Granules India’s ability to capitalize on this demand through its cost-effective production could significantly drive its long-term growth and influence its stock price.
• Innovation and R&D Investment: Granules India’s commitment to research and development (R&D) will play a critical role in its future. Investments in developing new formulations, complex generics, and biosimilars could diversify its product portfolio and increase revenue streams, enhancing the company’s market value by 2030.

• Sustainability and ESG Initiatives: Increasing focus on environmental, social, and governance (ESG) practices could shape investor preferences by 2030. Granules India’s efforts toward sustainability, reducing its environmental impact, and maintaining strong governance practices may attract more long-term investors, positively affecting its share price trajectory.

Granules India Ltd Shareholding Pattern

• Promoters: 38.9%
• FII: 19.5%
• DII: 14.9%
• Public: 26.8%

FOR MORE DETAIL FOLLOW THE OFFICIAL WEBSITE: http://www.granulesindia.com/

Granules India Ltd Financials

Read Also:- SCI Share Price Target Tomorrow 2024 To 2030- Market Overview, Income Statement